ARABINOSYL CYTOSINE - A 20-YEAR UPDATE

[1] CYTARABINE FOR ACUTE-LEUKEMIA IN ADULTS - EFFECT OF SCHEDULE ON THERAPEUTIC RESPONSE [J]. ARCHIVES OF INTERNAL MEDICINE, 1974, 133 (02) : 251 - 259

[2] BODEY GP, 1969, CANCER CHEMOTH REP 1, V53, P59

[3] HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - CONTRIBUTIONS TO OUTCOME OF CLINICAL AND LABORATORY ATTRIBUTES [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) : 532 - 543

[4] ESTEY E, 1986, BLOOD, V58, pA222

[5] FREIREICH EJ, 1967, CANCER RES, V27, P2573

[6] FREIREICH EJ, 1983, BLOOD CELLS, V9, P5

[7] KEATING MJ, 1985, SEMIN ONCOL, V12, P98

[8] PLUNKETT W, 1980, CANCER RES, V40, P588

[9] RUDNICK SA, 1979, CANCER-AM CANCER SOC, V44, P1189, DOI 10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO

[10] 2-O

[1] CYTARABINE FOR ACUTE-LEUKEMIA IN ADULTS - EFFECT OF SCHEDULE ON THERAPEUTIC RESPONSE [J]. ARCHIVES OF INTERNAL MEDICINE, 1974, 133 (02) : 251 - 259

[2] BODEY GP, 1969, CANCER CHEMOTH REP 1, V53, P59

[3] HIGH-DOSE CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ACUTE MYELOGENOUS LEUKEMIA - CONTRIBUTIONS TO OUTCOME OF CLINICAL AND LABORATORY ATTRIBUTES [J]. JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) : 532 - 543

[4] ESTEY E, 1986, BLOOD, V58, pA222

[5] FREIREICH EJ, 1967, CANCER RES, V27, P2573

[6] FREIREICH EJ, 1983, BLOOD CELLS, V9, P5

[7] KEATING MJ, 1985, SEMIN ONCOL, V12, P98

[8] PLUNKETT W, 1980, CANCER RES, V40, P588

[9] RUDNICK SA, 1979, CANCER-AM CANCER SOC, V44, P1189, DOI 10.1002/1097-0142(197910)44:4<1189::AID-CNCR2820440404>3.0.CO

[10] 2-O